Vivitrol | Addiction Professional Magazine Skip to content Skip to navigation


SCE: Be open to evidence-based treatment

March 9, 2018  |  Julie Miller, Editor in Chief
Experts speaking in Chicago at the Summit For Clinical Excellence, The Opioid Crisis: Strategies for Treatment and Recovery covered a number of treatment modalities that clinicians might not be embracing just yet.

Study offers reasons why alcohol medication adherence poses challenge

February 15, 2018  |  Gary A. Enos, Editor
Research reveals several factors that influence the ability of patients with an alcohol use disorder to stay on a daily medication regimen, including intense cravings and a weekend danger.

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

FDA clears electrical device to combat opioid withdrawal

November 15, 2017  |  Gary A. Enos, Editor
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.

Hospital boosts opioid patients' rapid access to medication

November 14, 2017  |  Gary A. Enos, Editor
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.

Opioid treatment programs growing, and expanding into other medications

August 23, 2017  |  Gary A. Enos, Editor
Today's opioid treatment programs (OTPs) are increasingly likely to be offering buprenorphine and injectable naltrexone treatment in addition to methadone.

NCAD: Doctor attacks misconceptions about opioid addiction medications

August 20, 2017  |  Gary A. Enos, Editor
The owner of Addiction Recovery Resources in Louisiana discussed why it makes sense to integrate 12-Step and medication approaches to opioid addiction treatment.

Could a device attached to the ear become a game-changer in detox?

April 12, 2017  |  Gary A. Enos, Editor
An electrical stimulation device that is approved for pain is gaining use as a method of easing withdrawal from opioids and facilitating access to longer-term treatment.

Ohio enacts limits on prescribing for acute pain

April 4, 2017  |  Gary A. Enos, Editor
New regulations on opioid prescribing in Ohio arrive at a time when some lawmakers are advocating even stricter limits.

App from SAMHSA guides medication treatment for opioid dependence

December 1, 2016  |  Gary A. Enos, Editor
The new MATx app is designed to share treatment strategies and other resources for the use of medications to treat opioid use disorders.

Health home model allows OTPs to cast a wider net

November 15, 2016  |  Rachael Zimlich, RN, Contributing Writer
Not only does the promising new health-home model require extra work in care coordination, it also requires a change in the way clinicians are thinking about care delivery.

Alkermes establishes grant program for nonprofits

September 16, 2016  |  Gary A. Enos, Editor
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.


Subscribe to Vivitrol